New capsule targets Cancer's genetic driver in advanced tumors
NCT ID NCT05265091
Summary
This study is testing an investigational capsule called KL590586 for adults with advanced solid tumors that have specific changes in a gene called RET. The main goals are to find a safe dose and see if the treatment can shrink tumors. It is for people whose cancer has progressed despite standard treatments or who cannot tolerate them.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sichuan Kelun Botai Biopharmaceutical Co.
Chengdu, Sichuan, 610000, China
Conditions
Explore the condition pages connected to this study.